Adenosine monophosphate- activated protein kinase- based classification of diabetes pharmacotherapy
Main Authors: | A Hajra, D Bandyopadhyay, S K Hajra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Journal of Postgraduate Medicine |
Online Access: | http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2017;volume=63;issue=4;spage=275;epage=275;aulast=Hajra |
Similar Items
-
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
by: D Dutta, et al.
Published: (2017-01-01) -
Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy”
by: D Dutta, et al.
Published: (2017-01-01) -
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
by: Yaeni Kim, et al.
Published: (2016-06-01) -
Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
by: Tae-Sun Ha, et al.
Published: (2014-03-01) -
The role of adenosine monophosphate-activated protein kinase in neurodegeneration in Parkinson's disease
by: Jovanović-Tucović Maja, et al.
Published: (2019-01-01)